 "pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing")
Shares of Dishman Carbogen Amcis were locked in 5 per cent lower circuit at Rs 169.40 on the BSE on Wednesday after the company reported a consolidated net loss of Rs 21.4 crore for the quarter ended June 2020 (Q1FY21). The pharmaceutical firm had posted profit of Rs 34.31 crore in the year-ago quarter.
Till 09:29 am, a combined around 30,000 equity shares had changed hands on the NSE and BSE. There were pending sell orders for 100,000 shares on both the exchanges. The stock had a strong run-up, and it hit a 52-week high of Rs 216.65 on
Till 09:29 am, a combined around 30,000 equity shares had changed hands on the NSE and BSE. There were pending sell orders for 100,000 shares on both the exchanges. The stock had a strong run-up, and it hit a 52-week high of Rs 216.65 on
